Bioreactor Market to reach $1.9 billion by 2024

1
Bioreactor Market to reach 1.9 billion by 2024
Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Bioreactor Market

• Global Market Insights, Inc. says Bioreactor
  Market size is set to exceed USD 1.9 billion by
  2024.
• Rising chronic disease prevalence and growing
  research in the field of biopharmaceuticals will
  drive the global bioreactor market size.
• Personalized medicines are changing the way many
  diseases are identified, classified, and treated.
  The growing personalized medicine market that
  involves a focused population base will further
  drive the bioreactor market size.
• Technological advances in manufacturing
  technology should improve flexibility, quality
  and scalability of operations with low capital
  and energy requirements.
• Biopharmaceuticals are individualized products
  with highly specific manufacturing requirements.
  Advanced biopharmaceutical manufacturing
  technologies have enabled the development of
  effective drug delivery systems and drug device
  combination products.

3
Continued...

• Biopharmaceutical contract manufacturing
  outsourcing should drive the industry growth due
  to rising demand for biopharmaceuticals along
  with innovative drug products entering the
  clinical trials.
• Large number of outsourcing services such as
  analytical, formulation, cell line development
  and small or large scale production related
  services should stimulate the business growth
  over the forecast years.
• Mammalian cells market revenue is estimated to
  exceed USD 1.5 billion by 2024. It is widely used
  owing to its preference to product complex
  therapeutic proteins and enhanced compatibility
  for posttranslational modifications.
• Monoclonal antibodies held more than 35 of the
  bioreactor market share in 2016, owing to
  increasing use in medical therapeutics attributed
  to its long half-life, high specificity,
  predictable pharmacokinetics, low toxicity, and
  high dose demand.
• Single use bubble column bioreactor market size
  should witness over 18 CAGR over the forecast
  years.

4
Continued...

• It is extensively used for cell line development,
  process development, and clinical trial
  manufacturing wherein they enhance the overall
  speed and effectiveness of media and cell line
  development.
• U.S. bioreactor market size was valued at over
  USD 170 million in 2016 and is anticipated to
  witness significant growth over the coming years.
• UK bioreactor market will witness over 17 CAGR,
  due to high healthcare spending and presence of
  large number of industry participants in this
  region.
• APAC will experience significant gains due to a
  trend shift from traditional methods to new
  production methods of monoclonal antibodies,
  recombinant proteins, and cell culturing by using
  advanced bioreactors.
• Bioreactor market participants are Eppendorf, GE
  Healthcare, Merck Millipore, Sartorius, Thermo
  Fisher Scientific, etc. Industry participants
  engage in strategic collaborations, mergers
  acquisitions coupled with new product launches in
  order to achieve competitive edge.

5
U.S. Bioreactor Market Share, By Technology, 2016

6

Browse Full Market Research Report On
Bioreactor Market _at_ http//bit.ly/2rek6vB
Request for a Sample of this Research
Report _at_ https//www.gminsights.com/request-sample
/detail/141 https//www.gminsights.com/request-sa
mple/detail/49
7
Stay In Touch Website www.gminsights.com Soci
al Media